The Stresa Seminar continues to be a valuable occasion for reflecting on and comparing the clinical research on headache. Questions were raised about the possibility to create and test new treatments for migraine, cluster and tension headaches. Among interesting innovations are studies on anti-CGRP monoclonal antibodies, which will soon be available in Italy to treat both migraine attacks and chronic migraines
The Stresa Seminar continues to be a valuable occasion for reflecting on and comparing the clinical research on headache. Questions were raised about the possibility to create and test new treatments for migraine, cluster and tension headaches. Among interesting innovations are studies on anti-CGRP monoclonal antibodies, which will soon be available in Italy to treat both migraine attacks and chronic migraines
interviews
Nuove vie di ricerca e nuovi farmaci
Cluster headache and CGRP antibodies
La dieta chetogenica nella cura dell'epilessia e dell'emicrania
Cefalee e vertigini: un'associazione che merita attenzione
Emicrania con aura: nuovi dati sui rischi vascolari
Le strategie per contrastare il "mal di testa da pillola"
I costi diretti e indiretti delle cefalee
Il ruolo della pressione intracranica nell'emicrania cronica
Neuromodulation, an alternative to drug therapy for headache
Il farmacista di comunità, sentinella del mal di testa
La prevenzione dell'emicrania in bambini e adolescenti
Nuovi nutraceutici nella prevenzione dell'emicrania
Headache: possible interactions between clinical psychology and pharmacology
